Talari, Talaei, Shajari, Vakili, and Taghaviardakani: Childhood cutaneous leishmaniasis: report of 117 cases from Iran
Cited By
Citations to this article as recorded by
Head and neck cutaneous leishmania: clinical characteristics, microscopic features and molecular analysis in a cohort of 168 cases
Gabriel Dunya, Robert Habib, Roger V. Moukarbel, Ibrahim Khalifeh
European Archives of Oto-Rhino-Laryngology.2016; 273(11): 3819.     CrossRef
Identification of Leishmania parasites in clinical samples obtained from cutaneous leishmaniasis patients using PCR-RFLP technique in endemic region, Sanliurfa province, in Turkey
Feridun Akkafa, Fuat Dilmec, Zuhre Alpua
Parasitology Research.2008; 103(3): 583.     CrossRef
The prevalence of cutaneous leishmaniasis in school children in southwestern Iran, 2009
Hojat Asgari Nezhad, Mohammad Mirzaie, Iraj Sharifi, Mehdi Zarean, Mojtaba Norouzi
Comparative Clinical Pathology.2012; 21(5): 1065.     CrossRef
Geographical distribution and molecular epidemiology of cutaneous leishmaniasis in Fars Province, southern Iran
Tahereh Davoodi, Ali Khamesipour, Saeed Shahabi, Fatemeh Gholizadeh, Daniel Pourkamal, Gholamreza Hatam
Environmental Science and Pollution Research.2022; 29(3): 4024.     CrossRef
Epidemiological trend of cutaneous leishmaniasis in two endemic focus of disease, south of Iran
Moosa Khosravani, Zahra Nasiri, Davood Keshavarz, Azam Rafat-Panah
Journal of Parasitic Diseases.2016; 40(4): 1609.     CrossRef
Spatio-temporal analysis of cutaneous leishmaniasis using geographic information system among Iranian Army Units and its comparison with the general population of Iran during 2005–2014
Reza Pakzad, Arasb Dabbagh-Moghaddam, Mehdi Mohebali, Saeid Safiri, Mohammad Barati
Journal of Parasitic Diseases.2017; 41(4): 1114.     CrossRef
Spatial modeling of cutaneous leishmaniasis in Iran from 1983 to 2013
Kourosh Holakouie-Naieni, Ehsan Mostafavi, Ali Darvishi Boloorani, Mehdi Mohebali, Reza Pakzad
Acta Tropica.2017; 166: 67.     CrossRef
Reprint of “Spatial modeling of Cutaneous Leishmaniasis in Iran from 1983 to 2013”
Kourosh Holakouie-Naieni, Ehsan Mostafavi, Ali Darvishi Boloorani, Mehdi Mohebali, Reza Pakzad
Acta Tropica.2017; 165: 90.     CrossRef
Molecular epidemiological survey of cutaneous leishmaniasis from Azad Jammu and Kashmir, Pakistan.
Nargis Shaheen, Naveeda Akhter Qureshi, Muhammad Zahid Qureshi, Huma Fatima, Muhammad Afzal, Saleh S Alhewairini
Acta Tropica.2020; 206: 105434.     CrossRef
La leishmaniose cutanée de l’enfant au Maroc : particularités cliniques et épidémiologiques
B. Baghad, M. Riyad, R. Razanapinaritra, H. Maksouri, H. Ben Errais, S. Chiheb
Annales de Dermatologie et de Vénéréologie.2020; 147(2): 106.     CrossRef
Distribution, clinical features, and epidemiology of cutaneous leishmaniasis: A case study of District Haripur, KPK, Pakistan
Muhaibullah Khan, Shehzad Ghayyur, Samina yasmin
Medical Reports.2023; 2: 100025.     CrossRef
Epidemiology and clinical features of parasitic disease Leishmaniasis. A case study from Pakistan
Muhaibullah khan, Sheraz Ahmad, Hamayun saeed, M. Junaid Akhtar, Amna Munir
Medical Reports.2024; 6: 100090.     CrossRef
A newly emerged cutaneous leishmaniasis focus in central Iran
Mahmoud Nateghi Rostami, Abedin Saghafipour, Ehsan Vesali
International Journal of Infectious Diseases.2013; 17(12): e1198.     CrossRef
Clinical and Epidemiological study of Cutaneous Leishmaniasis from two tertiary care hospitals of Jammu and Kashmir: an Emerging Disease in North India
Shagufta Rather, Mashkoor Wani, Faizan Younus Shah, Safia Bashir, Atiya Yaseen, Firdous Ahmad Giri, Rajesh Sharma, Sumaya Zeerak, Yasmeen Jabeen, Iffat Hassan, Devraj Dogra, Ruby Rishi
International Journal of Infectious Diseases.2020;[Epub]     CrossRef
Prevalence and epidemiologic profile of acute cutaneous leishmaniasis in an endemic focus, Southwestern Iran
Mohammad-Hossein Feiz-Haddad, Hamid Kassiri, Niusha Kasiri, Assiae Panahandeh, Masoud Lotfi
Journal of Acute Disease.2015; 4(4): 292.     CrossRef
Molecular diagnosis and epidemiological aspects of cutaneous Leishmaniasis in Aleppo: Current status
Lana Kourieh, Mohammad Y. Abajy, Mahasen Alkebajy, Silva Ishkhanian, Ream Nayal
Parasite Epidemiology and Control.2025; 28: e00412.     CrossRef
An overview of a diagnostic and epidemiologic reappraisal of cutaneous leishmaniasis in Iran
Mahin Farahmand, Hossein Nahrevanian, Hasti Atashi Shirazi, Sabah Naeimi, Zahra Farzanehnejad
The Brazilian Journal of Infectious Diseases.2011; 15(1): 17.     CrossRef
A molecular and parasitological survey on cutaneous leishmaniasis patients from historical city of Kashan in Isfahan province, center of Iran
Mohammad Reza Shiee, Homa hajjaran, Mehdi Mohebali, Abbas Doroodgar, Masoomeh Hashemi saadat, Aref Teimouri, Hassan Afzali, Mohammad Reza Shirzadi
Asian Pacific Journal of Tropical Disease.2012; 2(6): 421.     CrossRef
Epidemiological aspects of cutaneous leishmaniasis in Ilam province, west of Iran (2000–2007)
Hamid Kassiri, Narges Sharifinia, Mostafa Jalilian, Khadijeh Shemshad
Asian Pacific Journal of Tropical Disease.2012; 2: S382.     CrossRef
Epidemiological and pathological characteristics of Cutaneous Leishmaniasis from Baluchistan Province of Pakistan
Aisha Khan, Rawan Sajid, Shaista Gul, Ashiq Hussain, Mohammad Tahir Zehri, Shumaila Naz, Sami Simsek, Shahid Waseem, Muhammad Sohail Afzal, Syed Kamran Ul Hassan Naqvi, Muhammad Qasim, Haroon Ahmed
Parasitology.2021; 148(5): 591.     CrossRef
Effect of pentavalent antimony compounds on the inflammatory, hematological and biochemical parameters in patients with cutaneous leishmaniasis
Kadir Kaya
Cutaneous and Ocular Toxicology.2024; 43(4): 305.     CrossRef
Prevalence of cutaneous Leishmaniasis in the Middle East: a systematic review and meta-analysis
Mohsen Karami, Tahmineh Gorgani-Firouzjaee, Mohammad Chehrazi
Pathogens and Global Health.2023; 117(4): 356.     CrossRef
Systemic Meglumine Antimoniate in Cutaneous Leishmaniasis of Children: Clinical and Laboratory Complications
P. Layegh, Z. Khademi, M. Afzal Aghaee, T. Moghiman
Journal of the Pediatric Infectious Diseases Society.2015; 4(4): 356.     CrossRef
Epidemiological survey, molecular profiling and phylogenetic analysis of cutaneous leishmaniasis in Khyber Pakhtunkhwa, Pakistan
Wasia Ullah, Adil Khan, Sadaf Niaz, Maged A Al-Garadi, Nasreen Nasreen, Ayman A Swelum, Mourad Ben Said
Transactions of The Royal Society of Tropical Medicine and Hygiene.2024; 118(4): 273.     CrossRef
Leishmaniasis in Turkey: molecular characterization of Leishmania from human and canine clinical samples
Seray Ozensoy Toz, Abedelmajeed Nasereddin, Yusuf Ozbel, Hatice Ertabaklar, Gulnaz Culha, Naser Sevil, M. Ziya Alkan, Charles L. Jaffe
Tropical Medicine & International Health.2009; 14(11): 1401.     CrossRef
Childhood and adult cutaneous leishmaniasis in Tunisia
Ines Zaraa, Faten Ishak, Rym Kort, Dalenda El Euch, Mourad Mokni, Emna Chaker, Amel Ben Osman
International Journal of Dermatology.2010; 49(7): 790.     CrossRef
Atypical presentation of Old‐World cutaneous leishmaniasis, diagnosis and species identification by PCR
M Karamian, MH Motazedian, M Fakhar, K Pakshir, F Jowkar, H Rezanezhad
Journal of the European Academy of Dermatology and Venereology.2008; 22(8): 958.     CrossRef
Clinical, microscopic and molecular presentation in pediatric versus adult old world cutaneous Leishmaniasis
Gabriel Dunya, Asif Loya, Suad Taraif, Mohammad Adib Houreih, Ibrahim Khalifeh
Pediatric Dermatology.2020; 37(4): 656.     CrossRef
Geographic Information System‐Based Analysis of the Spatial and Spatio‐Temporal Distribution of Zoonotic Cutaneous Leishmaniasis in Golestan Province, North‐East of Iran
A. Mollalo, A. Alimohammadi, M. R. Shirzadi, M. R. Malek
Zoonoses and Public Health.2015; 62(1): 18.     CrossRef
The changing profile of cutaneous leishmaniasis in a focus of the disease in Jahrom district, southern Iran
M. H. Davami, M. H. Motazedian, B. Sarkari
Annals of Tropical Medicine & Parasitology.2010; 104(5): 377.     CrossRef
Knowledge, attitude, and practices related to cutaneous leishmaniasis in an endemic focus of cutaneous leishmaniasis, Southern Iran
Bahador Sarkari, Asgari Qasem, Mohammad Reza Shafaf
Asian Pacific Journal of Tropical Biomedicine.2014; 4(7): 566.     CrossRef
Nuclear Weapons and Neglected Diseases: The “Ten-Thousand-to-One Gap”
Peter J. Hotez
PLoS Neglected Tropical Diseases.2010; 4(4): e680.     CrossRef
Pediatric Cutaneous Leishmaniasis in an Endemic Region in Turkey: A Retrospective Analysis of 8786 Cases during 1998-2014
Mustafa Aksoy, Nebiye Doni, Hatice Uce Ozkul, Yavuz Yesilova, Nurittin Ardic, Abdullah Yesilova, Jennifer Ahn-Jarvis, Steve Oghumu, Cesar Terrazas, Abhay R. Satoskar, Paulo Filemon Pimenta
PLOS Neglected Tropical Diseases.2016; 10(7): e0004835.     CrossRef
Sporotrichoid leishmaniasis: a cross-sectional clinical, epidemiological and laboratory study in Rio de Janeiro State, Brazil
Livia Martins Veloso de Carvalho, Maria Inês Fernandes Pimentel, Fátima Conceição-Silva, Érica de Camargo Ferreira e Vasconcellos, Cláudia Maria Valete-Rosalino, Marcelo Rosandiski Lyra, Mariza de Matos Salgueiro, Maurício Naoto Saheki, Maria de Fátima Ma
Revista do Instituto de Medicina Tropical de São Paulo.2017;[Epub]     CrossRef
The Effects of Some Climate Factors upon Frequency Distribution of Local Sandflies Breed in Misan Province, Iraq
Rasha K A Alsaad, May H Kawan
The Iraqi Journal of Veterinary Medicine.2021; 45(1): 63.     CrossRef
Overexpression of Ubiquitin and Amino Acid Permease Genes in Association with Antimony Resistance in Leishmania tropica Field Isolates
Elham Kazemi-Rad, Mehdi Mohebali, Mohammad Bagher Khadem-Erfan, Homa Hajjaran, Ramtin Hadighi, Ali Khamesipour, Sassan Rezaie, Mojtaba Saffari, Reza Raoofian, Mansour Heidari
The Korean Journal of Parasitology.2013; 51(4): 413.     CrossRef
Novel Loci Controlling Parasite Load in Organs of Mice Infected With Leishmania major, Their Interactions and Sex Influence
Tatyana Kobets, Marie Čepičková, Valeriya Volkova, Yahya Sohrabi, Helena Havelková, Milena Svobodová, Peter Demant, Marie Lipoldová
Frontiers in Immunology.2019;[Epub]     CrossRef
Evaluation of Modified Novy-MacNeal-Nicolle Medium for Isolation of Leishmania Parasites from Cutaneous Lesions of Patients in Iran
J. Saki, L. Akhlaghi, S. Maraghi, A.R. Meamar, M. Mohebali, H. Oormazdi, E. Razmjou, S. Khademvata, F. Rahim
Research Journal of Parasitology.2009; 4(2): 56.     CrossRef
Pediatric Cutaneous Leishmaniasis
Shagufta Rather, Atiya Yaseen, Faizan Younus Shah, Mashkoor Wani, Kewal Krishan, Sumaya Zirak, Rajesh Sharma, Iffat Hassan, Devraj Dogra, Ruby Rishi
Indian Dermatology Online Journal.2021; 12(6): 852.     CrossRef
Spatial modeling of cutaneous leishmaniasis in Iranian army units during 2014-2017 using a hierarchical Bayesian method and the spatial scan statistic
Erfan Ayubi, Mohammad Barati, Arasb Dabbagh Moghaddam, Ali Reza Khoshdel
Epidemiology and Health.2018; 40: e2018032.     CrossRef
Pediatric Cutaneous Leishmaniasis in an Endemic Region in India
Abhay R. Satoskar, Saurabh Agrawal, Kanika Khandelwal, Steve Oghumu, Ram A. Bumb, Poonam Salotra
The American Journal of Tropical Medicine and Hygiene.2014; 91(5): 901.     CrossRef
Systemic Meglumine Antimoniate in Acute Cutaneous Leishmaniasis: Children versus Adults
Amir Ali Rahsepar, Pouran Layegh, Sara Rahsepar
The American Journal of Tropical Medicine and Hygiene.2011; 84(4): 539.     CrossRef
Pediatric Cutaneous Leishmaniasis in Hormozgan Province, Southeast Iran during 2016-2020: A Descriptive Epidemiological Study
Sajjad Fekrijaski, Mehdi Zare, Moussa Soleimani-Ahmadi, Kaveh Soleimani, Alireza Sanei-Dehkordi
Journal of Occupational Health and Epidemiology.2021; 10(4): 224.     CrossRef
Clinical Laboratory and Epidemiological Research on Cutaneous leishmaniasis in the South West of Iran
Hamid Kassiri, Khadijeh Shemshad, Ali Kassiri, Samaneh Shojaee, Narges Sharifinia, Masoomeh Shemshad
Archives of Clinical Infectious Diseases.2012; 7(4): 128.     CrossRef
Epidemiological Aspects of Cutaneous Leishmaniasis in Iran
Salman Khazaei, Abdollah Mohammadian Hafshejani, Mohammad Saatchi, Hamid Salehiniya, Shahrzad Nematollahi
Archives of Clinical Infectious Diseases.2015;[Epub]     CrossRef
The Incidence Rate of Cutaneous Leishmaniasis in Behbahan County of Khuzestan Province, Southwest of Iran
Khadijeh Shemshad, Hamid Kassiri, Samaneh Shojaee
Jundishapur Journal of Microbiology.2013;[Epub]     CrossRef
Mucosal leishmaniasis: A forgotten disease, description and identification of species in 50 Colombian cases
Sandra Muvdi-Arenas, Clemencia Ovalle-Bracho
Biomédica.2019; 39(Supl. 2): 58.     CrossRef

Abstract

Cutaneous leishmaniasis (CL), due to Leishmania major, is endemic in different parts of Iran and has long been recognized in most provinces of Iran. This study was conducted to determine the prevalence of childhood leishmaniasis in 3 areas at the southeast of Kashan. A descriptive study was carried out on all children referred to central laboratories during a 3-year period. Initial information including age, sex, sites of ulcer on the body, number of lesions, address, and the place of the disease was obtained. The study gathered 117 children, and the results showed a prevalence of 7.2% in patients with lesions among the population and 4.2% of people displayed lesion and scar. The ages of subjects were from 6 to 15 years (average 9.75 years). The boy: girl ratio was 1.2. All of our patients lived in an endemic area. The face was affected in 47.0% of cases. The encountered forms of leishmaniasis are as follows: papulonodular 27.4%, ulcer 60.7%, sporotrichoid 6%, impetiginous 2.5%, and erysipeloid 3.4%. Treatment with intramuscular meglumine antimoniate 20-30 mg/kg/day was done for 93 patients. Meglumine antimoniate treatment was tolerated with no side effects. All leishmaniasis lesions healed within an average period of 2-14 months. Hyperpigmented scars were formed in 25.6% of the patients, atrophic scars in 4.3%, and hypopigmented scars were in 3.4%, respectively. The findings of this study indicate increased prevalence of CL in the villages at the area of Kashan and Aran-Bidgol. The clinical finding patterns belonged to different endemic strains of L. major in Isfahan, which indicates the possible transmission of infection from Isfahan to this area.

INTRODUCTION

Leishmaniasis is endemic in 88 countries throughout Africa, Asia, Europe, and North and South Americas. There are an estimated 12 million cases worldwide, with 1.5 to 2 million new cases each year (WHO, 1984, 1990). Leishmania and Donovan, working separately, first described the Leishmania protozoan in 1903 (Herwaldt, 1999). Since then, this organism has been found to be a complex group of species, at least 20 of which cause infections in humans (Markele and Khaldoun, 2004). Some species cause visceral leishmaniasis, some cause cutaneous leishmaniasis, and some cause both. Cutaneous leishmaniasis (CL) occurs in the new world and in the old world. In the old world, the disease is primarily caused by Leishmania tropica in urban areas (dry type) and Leishmania major (wet type) in dry desert areas (Markele and Khaldoun, 2004).
The parasite enters the human host with the bite of the sandfly and is pulled into macrophages by ingestion. Leishmania parasites are able to survive the acidic environment of the lysosome and become amastigote forms. These forms are obligate, intracellular, nonmotile, and about 2-7 µm in diameter. This amastigote form causes disease in humans and affects cellular immunity. CL begins as an erythematous papule at the site of sandfly bite on exposed parts of the body. Eventually, a sandfly will pick up this form while feeding, and it will develop into the promastigote form again in the insect (Kafetzis, 2003; Markele and Khaldoun, 2004).
Cutaneous leishmaniasis (CL) is still considered an important health problem in many parts of the world, especially the Mediterranean region, some countries of Africa, and almost all countries of the Middle East, including Iran (Momeni, 1994; Ozbel et al., 1995;Khoury et al., 1996; Alimohammadian et al., 1999). The prevalence of infection is high in some provinces of Iran, including Isfahan (Nadim and Faghih, 1968;Salimi, 2000), Shiraz (Moaddeb et al., 1993), Khorasan (Javadian et al., 1967), and Khozestan and Kerman (Nadim and Seyedi, 1971). Isfahan is a well known endemic area of zoonotic cutaneous leishmaniasis (ZCL). In north east of Isfahan, the disease incidence is high, especially in rural areas (Nadim and Faghih, 1968; Salimi, 2000). In spite of some reports about increased rate of CL in north area of Isfahan Province, however, there have been no previous reports of endemicity of ZCL around Kashan, 230 km north of Isfahan.
Although this disease does not cause mortality, but because of cosmetic disfiguration, a prolonged period of lesions, great expense of treatment, and side effects of available drugs, it has created many problems (Edrissian et al., 1982; Momeni, 1994). During last years, valuable studies have been performed in Iran. According to those studies, the outbreaks of CL in Isfahan were 2.5% (Nadim and Faghih, 1968; Salimi, 2000). This study was performed in order to determine the abundance and characteristics of cutaneous leishmaniasis in the childhood patients. We aimed here to describe the epidemio-clinical profiles, therapeutic characteristics, and outcome data of CL in 3 areas of Kashan, Iran.

MATERIALS AND METHODS

This descriptive study was carried out on all patients clinically suspected of having CL who were referred to the central laboratory in Kashan, for parasitologic diagnosis during the period from 2001 to 2003. Kashan is an ancient city; the area has a desert climate, very hot in summer and cold in winter. The city is located 230 km north of Isfahan and 230 km south of Tehran.
The diagnosis of CL was based on clinical presentations and a positive parasitic smear. For each case having cutaneous lesions (ulcers or scars), a questionnaire was completed to record the necessary information such as name, age, sex, sites of ulcer on the body, address, data and place of acquiring the disease, previous travel history, or location of workplace.
A total of 1,625 patients with skin lesions, suspected of CL, from villages in 3 areas, i.e., Kashan, Abouzeidabad, and Aran-Bidgol, were selected for study. Skin scrapings from the edge of the lesion were obtained from each patient. The remaining skin scraping portion was smeared on a slide for staining with Giemsa and examined microscopically for presence of amastigotes. The χ2-test was used to determine statistically significant differences in the disease patterns and the prevalence between boys and girls.

RESULTS

During this 3-year period, information on 1,625 children showed that the prevalence of ulcerative localized CL was 7.2% (117 cases), and cases with scar and ulcer were 4.2% (68 cases), 3.0% (49 cases) were with active ulcers. Parasites were isolated in smears from the skin. Infections with Leishmania parasites were recorded in 53 girls (45.3%) and 64 boys (54.7%). The highest rates in both genders were recorded in the age group of 6-8 years (45.3%). The lowest rates (20.5%) were recorded in the age group of 12-15 years.
The overall scar rate was 4.2% and the prevalence of ulcers was 3%. This means a medium endemicity of the disease, which has recently become endemic, otherwise a higher scar rate should have been observed. Single lesions were seen in 50.9% of patients, appearing as a round papular plaque with a diameter of 4-80 mm. Double lesions were observed in 24.6% of patients and 29.4% of patients showed multiple (3-15) lesions. Lesions were mainly located on the face and neck (47.0%), compared with hands and arms (23.0%), and legs (16.3%). Multiple lesions appeared on 2 or more parts of the body in 17% of the cases. Detailed distribution of lesion and scar according to the number of lesions and scars were shown in Table 1.
The face and neck was the most commonly affected site (47.0%). On the face and neck, the cheek was the site of highest involvement (45.5%) and the chin was the site of lowest involvement (5.5%) (Table 2). The duration of the disease at the time of presentation ranged from 20 days to 5 years with an average duration of 8-12 mo.
All slides, which have been prepared by scraping the edges of ulcers of all patients contained parasites morphologically compatible with L. major (a large vacuole in the cytoplasm). The affected children had an average age of 9.75 years. The age range of the patients was 6-15 years. The sex ratio (boy 64: girl 53) was 1.2. The age groups and sex distribution of CL are shown in Table 3.
Residence, workplace, travel history of patients and the time of appearance of the lesions were important data for determining the locations where the infections might have taken place. The distribution of positive cases in the villages of Abouzeidabad, Kashan, and Aran-Bidgol is showed in Fig. 1. The highest infection rate (47.0%) was recorded in patients who are living or traveling in the villages at the area of Abouzeidabad. The lowest rate (18.0%) was recorded in patients living in the villages at the area of Kashan
We encountered 5 clinical forms of CL; papulonodular (27.4%), ulcer (60.7%), sporotrichoid (6.0%), impetiginous (2.5%), and erysipeloid (3.4%). Treatment and follow-up were well documented in 93 (79.5%) of 117 patients. Twenty-two patients were lost to follow-up and 2 child healed spontaneously. Two patients (1.7%) underwent treatment with intralesional meglumine antimoniate therapy weekly until recovery. Meglumine antimoniate was well tolerated without any side effects.
In follow-up of 93 patients, all CL lesion healed within an average period of 2 to 14 mo. Hyperpigmented scars were seen in 25.6%, atrophic scars in 4.3%, and hypopigmented scars in 3.4% of the patients.

DISCUSSION

This study reports cases of human CL from 3 different regions in southeast of Kashan, Iran. The prevalence rate of 3.0% reported in this study, seems to be rather high, but could reflect the occurrence of an almost severe outbreak of CL in this area. In clinical aspects, 3% of people under survey showed single or multiple ulcers, and 4.2% of them showed scars on their face-neck, hand, arm, legs, and other parts of the body. The overall rate of scars only was 1.4%, and the prevalence of ulcers was 3%. The frequency of lesions was almost twice as high as that of scars only, indicating the increasing progression of the outbreak during last years. The majority of ulcers or scars were seen on the face and neck, and upper parts of the body, which may be due to slipping out of the covered area on the terraces or house yards without using bednets during summer. The duration of active lesions was restricted to less than a year in most cases, while healing occurred in 79.5% of the patients within months. The endemic nature of the cases in these areas indicates the recent spread of the disease to these areas. Clustering of cases was recorded in endemic areas of Kashan and Aran-Bidgol; the highest number of cases was reported mostly in Abouzeidabad. The prevalence of CL was equal in the countryside of Kashan and Aran-Bidgol. Several previous studies reported on the endemicity of CL on both sides of Kashan and Aran-Bidgol (Yaghoobi et al., 2001, 2003, 2004).
The disease is endemic for many years in Abouzeidabad, and in the villages of Kashan area. The endemicity of the disease has been maintained due to the presence of the vector Phlebotomus papatasi and the reservoir host Rhombomys opimus in those areas (Alimohammadian et al., 1999). The predilection of the infection to boys (54.7%) than girls (45.6%) was also reported by other workers. This difference might be explained by more frequent exposure of boys to sandfly bites during their travel and work activities in the endemic areas (Kharfi et al., 2004). Significant differences were observed between infected males and females (P < 0.05). The χ2-test also showed non significant differences of host ages on scar/lesion rates.
The lesions were most frequently seen on the face and neck (47.0%), hands and arms (19.7%), legs (16.3%), and other parts of the body (17.0%). Customs and the geographic location of Kashan, presence of contaminated centers in Badrood and Ardestan, and traverse of susceptible hosts, especially the migration of Afgahans to these areas, are most important factors in expanding the disease (Javadian et al., 1967; Salimi, 2000). Phlebotomus longipes can not bite over the clothing, but bite the exposed areas of the body to suck the blood, so the lesions mainly appear in hands, face and legs (Nadim and Seyedi, 1971). Considering the fact that about 48.7% of patients had one or more skin lesions, we concluded that a sandfly, because of its physiologic characteristics, bites the host more than one time, and from every area of the bite, parasites enter the blood (Ahmadiyazdi et al., 2004; Yaghoobi et al., 2002; Ajdary et al., 2000).
The transmission cycle of Leishmania organisms requires an arthropod vector and a mammalian reservoir. The arthropod vectors are females of sandfly species. Adult female sandflies inject saliva containing Leishmania organisms into the wound. In the vector, the parasites are flagellated and extracellular; the organism is in its flagellated, promastigote form. Once inside the human, canine, or rodent host, the parasites are internalized by dermal macrophages. Here, they exit as intracellular, non-flagellated amastigotes. The cycle is completed when the sandfly feeds on an infected host, and the parasite moves to the gut where metamorphosis into the promastigote form takes place (Hanafi et al., 2002). As shown in our study, childhood CL mostly afffects school-age children having a history of stay in an endemic area. Even infants can be affected. Most of our patients were living in the southeast of Kashan, which may be associated with the geographical situation of Isfahan.
CL lesions can be misdiagnosed, especially in children, as impetigo, prurigo and folliculitis. Diagnosis is easily performed by the parasitology smear, but in endemic areas the diagnosis is established on clinical examinations (Berman, 1997). We used intramuscular meglumine antimoniate in cases of resistance to local treatments, multiplicity of the lesions (over 5), proximity to the cartilage and joint, and locations on the leg and foot. Our patients received the drug at the dose of 20-30 mg/kg/day with no side effects. Some authors reported success by using a dose of 10 mg/kg/day in children in order to prevent cardiac side effects (Selim et al., 1990; Talari et al., 1999; Talari and Sadr, 2005; Sadr and Talari, 1998).
In conclusion, childhood CL was frequent in the surveyed areas of Iran. The disease had the characteristics of endemic leishmaniasis. The standard therapy for multiple lesions by intramuscular injection with meglumine antimoniate was satisfactory, although further prospective studies are needed.

ACKNOWLEDGMENTS

The authors are grateful to the examinees who participated in this study.

REFERENCES

1. Ahmadiyazdi C, Narmani MR, Sadri B. Cutaneous leishmaniasis in Iran. The Internet Journal of Infectious Diseases. 2003. 3:1-9.

2. Ajdary S, Alimphammadian MH, Kharazimi A. Comparsion of immune profile of non healing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect Immun. 2000. 68:1760-1764. PMID: 10722561.
crossref pmid pmc
3. Alimohammadian MH, Almasi H, Khabiri AR, Hatam G, Amirkhani A. Identification of species and characteristics of an outbreak of cutaneous leishmaniasis in a new focus of Iran. Iran Biomed J. 1999. 3:31-39.

4. Berman JD. Human leishmaniasis: Clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin Infect Dis. 1997. 24:684-703. PMID: 9145744.
crossref pmid
5. Edrissian GH, Zoevein Z, Nadim A. A simple tecchnique for preparation of smears from the ear of Rhombomys opimus for the detection of leishmanial infection. Trans R Soc Trop Med Hyg. 1982. 76:706-707. PMID: 7179430.
crossref pmid
6. Hanafi AA, Dehghani A, Jafari R, Ehrampoosh MH. Efficacy of control program of zoonotic cutaneous leishmaniasis in a new focus of the disease. Med J Mashhad University of Medical Sciences. 2002. 46:80-87.

7. Herwaldt BL. Leishmaniasis. Lancet. 1999. 354:1191-1199. PMID: 10513726.
crossref
8. Javadian E, Nadim A, Tahvildari A, Assefi V. Epidemiology of cutaneous leishmaniasis in Korassan Iran. Bull Soc Pathol Exot Filiales. 1976. 69:140-143. PMID: 1037090.

9. Kafetzis DA. An overview of pediatric leishmaniasis. J Postgrad Med. 2003. 49:31-38. PMID: 12865569.
crossref
10. Kharfi M, Benmously R, Fekih N, Daoud M, Kamoun MR. Childhood leishmaniasis: Report of 106 cases. Dermatol Online J. 2004. 10:6. PMID: 15530296.
pmid
11. Khoury S, Saliba EK, Oumeish OY, Tawfig MR. Epidemiology of cutaneous leishmaniasis in Jordan. Int J Dermatol. 1996. 35:566-559. PMID: 8854153.
crossref pmid
12. Markele WH, Khaldoun MMO. Cutaneous leishmaniasis: recognition and treatment. 2004. American Family Physician; 1-9.

13. Moaddeb A, Gettner S, Ardehali S. Studies on the causative agent of cutaneous leishmaniasis in Shiraz Iran. Irn J Med Sci. 1993. 18:28-33.

14. Momeni A. Clinical picture of cutaneous leishmaniasis in Isfahan, Iran. Int J Dermatol. 1994. 33:260-265. PMID: 8021082.
crossref pmid
15. Nadim A, Faghih MA. The epidemiology of cutaneous leishmaniasis in Isfahan province of Iran. Trans R Soc Trop Med Hyg. 1968. 62:534-542. PMID: 5691462.
crossref
16. Nadim A, Seyedi RMA. A brief review of the epidemiology of various types of leishmaniasis in Iran. Acta Med Iran. 1971. 8:99-106.

17. Ozbel Y, Turgay N, Ozensoy S, Ozbilgin A, Alkan MZ. Epidemiology, diagnosis and control of leishmaniasis in the Mediterranean region. Ann Trop Med Parasitol. 1995. 89:89-93. PMID: 8745931.

18. Sadr F, Talari SA. Effect of glucantime on electrocardiogram of patients suffering from cutaneous leishmaniasis. Feyz, Kashan University of Medical Sciences. 1998. 5:13-20.

19. Salimi M. A clinical and epidemiological comparison on the cutaneous leishmaniasis in the city and villages of Isfahan. Iran J Public Health. 2000. 2:214-219.

20. Selim MM, Vlasin Z, Jaroskova L. Leishmaniasis, currently recommended treatment. Int J Dermatol. 1990. 29:318-321. PMID: 2163368.
crossref pmid
21. Talari SA, Sadr F. Treatment of cutaneous leishmaniasis: effectiveness, and adverse effects of the drugs. Feyz, Kashan University of Medical Sciences. 2005. 33:85-94.

22. Talari SA, Vakili Z, Emami AH. Effect of glucantime on blood parameters in patients with cutaneous leishmaniasis. Feyz, Kashan University of Medical Sciences. 1999. 10:17-22.

23. World Health Organization. Expert committee: the leishmaniasis. WHO Tech Rep Ser No. 701. 1984. 2-4.

24. World Health Organization. Expert committee: epidemiological aspects. Control of the leishmaniasis. WHO Tech Rep Ser No. 793. 1990. 41-46.

25. Yaghoobi MR, Akhavan AA, Zahrai AR. Epidemiological study in a new focus of cutaneous leishmaniasis in the Islamic Republic of Iran. East Mediterr Health J. 2003. 9:816-826. PMID: 15748078.

26. Yaghoobi MR, Hanafi AA, Akhavan AA, Zahrai AR, Mohebali M. Epidemiological study in a new focus of cutaneous leishmaniasis due to Leishmania major in Ardestantown, central Iran. Acta Trop. 2001. 79:115-121. PMID: 11369303.
crossref pmid
27. Yaghoobi MR, Hanafi AA, Javadian E, Mohebali M. A new focus of cutaneous leishmaniasis caused by Leishmania tropica. Saudi Med J. 2002. 23:291-294. PMID: 11938418.
pmid
28. Yaghoobi MR, Jafari R, Hanafi AA. A new epidemic focus of zoonotic cutaneous leishmaniasis in central Iran. Ann Saudi Med. 2004. 24:98-101. PMID: 15323269.

Fig. 1
Distribution of cutaneous leishmaniasis cases according to the place of residence in Iran.
kjp-44-355-g001
Table 1.
Distribution and location of lesions and scars in patients with childhood cutaneous leishmaniasis in Iran
Characteristics % of cases with cutaneous lesions % of cases with scars
Number of lesions
 Single form 51.3 76.9
 Double form 23.0 9.4
 Multiple form 25.7 13.7
Locations
 Face and neck 47.0 37.6
 Hand and arm 19.7 23.9
 Legs 16.3 22.2
 Other parts of body 17.0 16.3
Table 2.
Clinical location of lesions of childhood cutaneous leishmaniasis in Iran
Location Number (%)
Cheek 25 45.5
Forehead 10 18.2
Nose 5 9.0
Chin 3 5.5
Neck 12 21.8
Table 3.
Age and sex distribution of 117 cutaneous leishmaniasis cases in Iran
Age group (year) Female Male Total No. of cases (%)
6-8 29 (45.3) 24 (45.3) 53 (45.3)
9-11 22 (34.4) 18 (33.9) 40 (34.2)
12-15 13 (20.3) 11 (20.7) 24 (20.5)
Total 64 53 117
1